More about Science
Choose a therapeutic area to find related scientific content
Diabetes
Neurology
Rare Diseases
Rare Blood Disorders
Explore Content
Explore the most recently added content
Academy of Knowledge - Prof. Gavin Giovannoni
Academy of Knowledge - Prof. Jiwon Oh
Fabry Disease & Cardiology
Fabry Disease and Nephrology
Support for your Patients
Discover the selection of support materials for patients from different therapeutic areas
Patient Support | Diabetes
Toujeo® Coach | Toujeo® (insulin glargine 300 units/mL)
Our Products
---Copy.png/jcr:content/AUBAGIO_logo_RGB%20(1)%20-%20Copy.png){kind=logo}
Prescribing Information GB
Prescribing Information NI
MAT-XU-2200676 (v2.0)
Date of preparation: August 2022
MAT-GB-2105812 (v2.0)
Date of preparation: August 2022
MAT-XU-2201444 (v2.0)
Date of preparation: August 2022
.png/jcr:content/Lemtrada-triangle-logo-product-card%20(1).png){kind=logo}
Prescribing Information GB
Prescribing Information NI
MAT-XU-2200680 (v2.0)
Date of preparation: August 2022
.png/jcr:content/Myozyme-logo%20(1).png){kind=logo}
MAT-GB-2105179 (v2.0)
Date of preparation: August 2022
SULIQUA
insulin glargine lixinatide
MAT-GB-2105438 (v3.0)
Date of preparation: August 2022
MAT-GB-2105435 (v2.0)
Date of preparation: August 2022
▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.
MAT-GB-2105264 (v2.0)
Date of preparation: April 2022
